Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing

  • Wilson M
  • Naccache S
  • Samayoa E
  • et al.
750Citations
Citations of this article
708Readers
Mendeley users who have this article in their library.

Abstract

A 14-year-old boy with severe combined immunodeficiency presented three times to a medical facility over a period of 4 months with fever and headache that progressed to hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding to leptospira infection. Clinical assays for leptospirosis were negative. Targeted antimicrobial agents were administered, and the patient was discharged home 32 days later with a status close to his premorbid condition. Polymerase-chain- reaction (PCR) and serologic testing at the Centers for Disease Control and Prevention (CDC) subsequently confirmed evidence of Leptospira santarosai infection. Copyright © 2014 Medical Society.

Cite

CITATION STYLE

APA

Wilson, M. R., Naccache, S. N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., … Chiu, C. Y. (2014). Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing. New England Journal of Medicine, 370(25), 2408–2417. https://doi.org/10.1056/nejmoa1401268

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free